HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First trimester disulfiram exposure: report of two cases.

Abstract
Disulfiram has been used effectively to deter alcohol consumption in patients with a history of alcohol abuse. Its use in reproductive age women has become increasingly common in recent years, intensifying the risk of fetal exposure. Nonspecific but significant abnormalities have been described in the infants of women treated with disulfiram in the first trimester of their pregnancies. Based on these data, authors have previously exposure is confirmed despite a lack of any pattern to the defects reported. We report the outcomes of two pregnancies with first trimester disulfiram exposure. In both cases, the timing and dose of disulfiram was known. In one case, disulfiram was the only potential teratogen exposed to the fetus. Both neonates were normal at birth and have shown subsequent normal development. This report suggests that the poor prognosis previously given to fetuses exposed to disulfiram in the first trimester may not be warranted.
AuthorsG D Helmbrecht, I A Hoskins
JournalAmerican journal of perinatology (Am J Perinatol) Vol. 10 Issue 1 Pg. 5-7 (Jan 1993) ISSN: 0735-1631 [Print] United States
PMID8442800 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Disulfiram
Topics
  • Abnormalities, Drug-Induced (prevention & control)
  • Adult
  • Alcoholism (drug therapy)
  • Disulfiram (therapeutic use, toxicity)
  • Female
  • Fetus (drug effects)
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Complications (drug therapy)
  • Pregnancy Outcome (epidemiology)
  • Pregnancy Trimester, First
  • Prenatal Exposure Delayed Effects

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: